Condition: Cow's Milk Protein Allergy · Sponsor: Nutricia UK Ltd
This non-inferiority study aims to determine whether a hydrolysed rice protein formula is as effective as a cow's milk protein based extensively hydrolysed formula using a double-blind, randomised-controlled design over a 28-day intervention period followed by a 2-month follow-up period in infants 0-13 months of age presenting with symptoms/clinical history suggestive of cow's milk allergy. The primary outcome is growth, and secondary outcomes are gastrointestinal tolerance, and differences in intake, allergic symptoms, parental QOL, acceptability, dietary intake, and safety.
This description comes directly from the study's public registry record.
Isabel Evans, MSc · 07385000738 · Isabel.EVANS@danone.com
Gary P Hubbard, PhD · 07738024720 · gary.hubbard@nutricia.com
Always discuss trial participation with your own doctor first.
| Gloucestershire Royal NHS Trust | Gloucester, Gloucestershire, United Kingdom | Recruiting |
| Bristol Royal Hospital for Children | Bristol, Somerset, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06288503